HeyJared1nessAgency Insights
Healthcare digital marketing insights narrated by AI. Compliance strategy, patient acquisition, and AI optimization from 1nessAgency.
- Indexed episodes, last 90 days
- 40
- Latest publication
- Sep 13, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 10, 2026
Latest episodes
Consolidation Wave Sweeps Rural America With Largest Hospital Network Boom in Years (opens the original)
Read excerpt
Networks this size don't market themselves. Individual hospitals within them often carry legacy brand identities, fragmented digital presences, and patient engagement tools built for standalone facilities , not for coordinated regional systems competing against urban health systems for the same pati
Federal Investment in Agentic AI Agents Signals End of Email-Driven Patient Engagement (opens the original)
Read excerpt
The federal government is writing a check that could redefine how health systems market cardiovascular services. ARPA-H, the Advanced Research Projects Agency for Health, is investing $62 million to develop agentic AI agents for heart care, marking the first major federal investment in autonomous AI
Boston Scientific Restores Remote Monitoring as FDA Clears Device Safety Fix (opens the original)
Read excerpt
Boston Scientific restored remote monitoring capabilities for its cardiac implantable electronic devices (CIEDs) following a service disruption that left patients and clinicians without real-time data transmission from pacemakers, defibrillators, and cardiac resynchronization therapy devices [1]. Th
HHS Installs Four New FDA Executives to Accelerate Pharmaceutical Review Process (opens the original)
Read excerpt
The FDA is simultaneously reshuffling its senior leadership and opening public comment on how to regulate generative AI-enabled medical devices , and the window for healthcare marketers to shape, anticipate, and position around that regulatory reality is closing faster than most organizations recogn
Pancreatic Cancer Gets First Precision Drug as FDA Breaks Treatment Stalemate (opens the original)
Read excerpt
The approval targets adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent regimens [1]. Between 90% and 95% of all pancreatic cancer diagnoses fall into the adenocarcinoma category, meaning this is not a niche pat
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.